Physician-pharmacist collaboration may increase adherence to opioid addiction treatment
NIH-supported pilot study found team-based approach may improve buprenorphine care.
WHAT:
A collaborative approach to treating opioid use disorder that relies heavily on community pharmacists is feasible and may increase adherence and participant satisfaction, according to a pilot study published today in Addiction. The study was supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, through the NIDA Center for the Clinical Trials Network.
Most people with opioid use disorder who would benefit from medication do not receive it. Buprenorphine is a safe and effective ...












